RecruitingNot ApplicableNCT06867861

Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes

Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes: A Randomized Controlled Trial

Sponsor

Eastern Virginia Medical School

Enrollment

110 participants

Start Date

Feb 24, 2025

Study Type

INTERVENTIONAL

Conditions

Gestational Diabetes Mellitus (GDM)

Summary

The hypotheses to be tested are 1) Fiber supplementation will decrease the need for medication in patients with gestational diabetes, and 2) Fiber supplementation will decrease adverse maternal and neonatal outcomes in these patients. In this study, the investigators will conduct a randomized controlled trial to limit bias in evaluating these hypotheses.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Fiber for people with gestational diabetes mellitus (gdm). The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTFiber

Psyllium fiber supplement capsules, 2g soluble fiber per capsule. They will be instructed to take 4 capsules twice daily for a total of 16g supplemental soluble fiber per day. This will be continued throughout pregnancy.